Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors

Leuk Res. 1999 May;23(5):507-12. doi: 10.1016/s0145-2126(99)00040-5.

Abstract

To elucidate the roles of serine/threonine protein phosphatases type 1 (PP1) and type 2A (PP2A) in methylprednisolone-induced differentiation of HL60 cells into granulocytes and K562 cells into monocytes, we examined the effect of serine/threonine protein phosphatase inhibitors, okadaic acid and Cal-A on the proliferation/differentiation of HL60 and K562 cells. Okadaic acid and Cal-A augmented methylprednisolone induced granulocytic differentiation and cell death of HL60 cells and monocytic differentiation and cell death of K562 cells in different dose ranges, respectively. These data suggest an important role of PP1 and PP2A in the mechanism leading to differentiation of leukemic cells.

MeSH terms

  • Cell Death / drug effects
  • Cell Differentiation / drug effects
  • Enzyme Inhibitors / pharmacology
  • HL-60 Cells
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / pathology
  • Marine Toxins
  • Methylprednisolone / therapeutic use*
  • Okadaic Acid / pharmacology
  • Oxazoles / pharmacology
  • Phosphoprotein Phosphatases / metabolism*

Substances

  • Enzyme Inhibitors
  • Marine Toxins
  • Oxazoles
  • Okadaic Acid
  • calyculin A
  • Phosphoprotein Phosphatases
  • Methylprednisolone